These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Metalloproteinases at the surface of small extrcellular vesicles in advanced ovarian cancer: Relationships with ascites volume and peritoneal canceromatosis index. Yunusova NV; Patysheva MR; Molchanov SV; Zambalova EA; Grigor'eva AE; Kolomiets LA; Ochirov MO; Tamkovich SN; Kondakova IV Clin Chim Acta; 2019 Jul; 494():116-122. PubMed ID: 30904547 [TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients. Yunusova N; Dzhugashvili E; Yalovaya A; Kolomiets L; Shefer A; Grigor'eva A; Tupikin A; Kondakova I; Tamkovich S Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613908 [TBL] [Abstract][Full Text] [Related]
8. Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours. Nagare RP; Sneha S; Sidhanth C; Roopa S; Murhekar K; Shirley S; Swaminathan R; Sridevi V; Ganesan TS Cancer Biomark; 2020; 28(3):397-408. PubMed ID: 32224528 [TBL] [Abstract][Full Text] [Related]
9. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell]. Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422 [No Abstract] [Full Text] [Related]
10. Nanomechanical sandwich assay for multiple cancer biomarkers in breast cancer cell-derived exosomes. Etayash H; McGee AR; Kaur K; Thundat T Nanoscale; 2016 Aug; 8(33):15137-41. PubMed ID: 27492928 [TBL] [Abstract][Full Text] [Related]
11. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258 [TBL] [Abstract][Full Text] [Related]
12. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients. Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137 [TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer. Calaf GM; Ponce-Cusi R; Abarca-Quinones J Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159 [TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of Blood Exosomes from Healthy Females and Breast Cancer Patients Reveals an Association between Different Exosomal Bioactivity on Non-tumorigenic Epithelial Cell and Breast Cancer Cell Migration in Vitro. Tutanov O; Orlova E; Proskura K; Grigor'eva A; Yunusova N; Tsentalovich Y; Alexandrova A; Tamkovich S Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218180 [TBL] [Abstract][Full Text] [Related]
17. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483 [TBL] [Abstract][Full Text] [Related]